Arcutis Biotherapeutics Inc (ARQT)

SG&A Expenses

$297.60M

TTM · Period ending: · USD

ARQT logo

ARQT SG&A Expenses

Latest reported$297.60M
ARQT SG&A Expenses ($695.00K → $297.60M)
High-resolution chart · PNG

ARQT sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arcutis Biotherapeutics Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
274,553,000
229,391,000
185,145,000
122,124,000
60,971,000
20,882,000
6,415,000
1,795,000
695,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.